Introduction
INCLIVA Health Research Institute manages the clinical studies (trials, observational studies, and research projects) carried out by the Hospital Clínico Universitario de Valencia and the Valencia Clínico-Malvarrosa Health Department researchers.
Clinical Studies 2020
As a result of its activity along 2020, the INCLIVA has managed a total of 206 studies (clinical trials and observational studies).
The following table shows the number of clinical trials and other studies according to their phase and department.
Phase I | Phase II | Phase III | Phase IV | Others | Observational | TOTAL | |
Cardiology | – | 4 | 6 | 1 | – | 10 | 21 |
Haematology | 3 | 2 | 12 | – | – | 3 | 20 |
Digestive Medicine | – | 4 | 3 | 2 | 1 | 4 | 14 |
Internal Medicine | 2 | 2 | 6 | – | – | 3 | 13 |
Nephrology | – | 3 | 1 | 1 | 1 | 2 | 8 |
Neurology | 1 | – | 9 | 2 | 1 | 2 | 15 |
Oncology | 27 | 25 | 15 | – | – | 7 | 74 |
Others | – | 3 | 12 | 2 | 5 | 19 | 41 |
TOTAL | 33 | 43 | 64 | 8 | 8 | 50 | 206 |
The following table shows the distribution of trials submitted in 2020 by sponsor type
PROMOTER | |
Hospital Clínico Universitario De Valencia/INCLIVA researchers | 17 |
Independent Clinical Research | 49 |
Comercial Research | 140 |
Activity last 5 years
The following table shows the number of studies managed annually, showing an average of over 150 trials per year, with a clear increase in 2020.
Year | Processed studies |
2016 | 146 |
2017 | 143 |
2018 | 172 |
2019 | 159 |
2020 | 206 |
Ongoing studies
579 clinical studies were ongoing during 2020. The following table shows the breakdown by department and development phase.
Department | |
---|---|
Primary Health Care | 9 |
Anesthesia and Reanimation | 18 |
Cardiology | 51 |
General Surgery | 6 |
Endocrinology | 9 |
Pharmacy | 7 |
Gynecology and Obstetrics | 80 |
Haematology | 44 |
Digestive Medicine | 18 |
Internal Medicine | 15 |
Nefrology | 5 |
Neurology | 32 |
Medical Oncology | 246 |
Pediatrics | 5 |
Infectious Diseases Unit | 6 |
Urology | 5 |
Others | 17 |
TOTAL | 579 |
Phase | |
---|---|
Phase I | 56 |
Phase II | 111 |
Phase III | 192 |
Phase IV | 27 |
Observational | 114 |
Others | 8 |
TOTAL | 579 |